What's breaking now, across thousands of outlets.
European regulators on Thursday detailed their skepticism of data behind Amgen's rare disease drug Tavneos, explaining a decision last week to pull the drug from the market there. In new documents ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- Half of participants in a new, increasingly popular fitness competition called HYROX said they had sustained an injury during training for it during the previous year, an…
About 26 months after failing two Phase 3 trials, an epilepsy treatment candidate is getting plucked off biopharma's shelves and will be given a new chance at life.
There are new rules for those who don’t have a permanent residence permit or citizenship and need to go to a public hospital.
A compound produced by bacteria in many people's digestive tracts increases the risk of developing Alzheimer's disease and speeds cognitive decline in dementia patients, making it a potential target…
A new report documenting California's rapidly growing silicosis epidemic among quartz countertop workers underscores the urgent need for a national effort focused on stronger surveillance, earlier…
'Childhood vaccination continues to be one of our most powerful tools to prevent illness and support child health in Canada,' the agency wrote.
